Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3256993 | Clinical Immunology | 2012 | 4 Pages |
Abstract
A patient presented with late onset disseminated nontuberculous mycobacterium (NTM) infection due to a novel interleukin-12/interleukin-23 receptor β1 (IL-12/IL-23Rβ1) mutation, r.1561C>G, leading to the amino acid substitution R521G. This is the second patient reported with a partial IL-12/IL-23Rβ1 defect.
► We report a novel IL-12/IL-23Rβ1 mutation, r.1561C>G. ► It is only the second patient with a partial IL-12/IL-23Rβ1 defect. ► The patient present with a late onset disseminated nontuberculous mycobacterium infection.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Judith Potjewijd, Roelof A. de Paus, Annelies van Wengen, Jan Damoiseaux, Annelies Verbon, Esther van de Vosse,